Clinical trialNCT07148193RecruitingObservational

Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)

SponsorTechnische Universität DresdenEnrollment1,600Medical CareQuality of Life (QOL)SarcomaSurvivorship

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study PROSa+ aims to assess patient-reported outcomes (PROs), patient-reported experiences (PREs), and the socioeconomic situation of long-term sarcoma survivors (≥ 5 years post-diagnosis, with or without active disease) in Germany. The mixed-methods research design includes a multicenter observational study with a cross-sectional questionnaire survey involving 1,600 participants (paper, online), qualitative interviews with up to 60 participants, and longitudinal analyses combining data from existing sarcoma registries and the previous PROSa study conducted between 2017 and 2020.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jens Jakob, Prof. Dr.
Sarcoma Center Mannheim
Principal Investigator
clinicaltrials.gov ↗
Karen Steindorf, Prof. Dr.
DKFZ Heidelberg
Principal Investigator
clinicaltrials.gov ↗
Markus Wartenberg
Deutsche Sarkom-Stiftung
Principal Investigator
clinicaltrials.gov ↗
Martin Eichler, Dr.
TU Dresden & NCT/ UCC Dresden
Principal Investigator
clinicaltrials.gov ↗
Richard F. Schlenk, Prof. Dr.
University Hospital Heidelberg
Principal Investigator
clinicaltrials.gov ↗
Uta Dirksen, Prof. Dr.
University Hospital, Essen
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany

Technical University Dresden
Dresden, Saxony, Germany
Recruiting
University Hospital Essen
Essen, Germany
Not, yet, recruiting
Nct Heidelberg
Heidelberg, Germany
Recruiting
Sarcoma Center Mannheim
Mannheim, Germany
Recruiting
Deutsche Sarkom-Stiftung
Wölfersheim, Germany
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Nov 2025
Primary completion: 30 Sept 2027
Completion: 30 Sept 2027
Last update posted: 8 Dec 2025
Registered enrollment: 1,600
Registry id: NCT07148193

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.